Bio-markers of Not-celiac Wheat Sensitivity
Launched by UNIVERSITY OF PALERMO · Jan 4, 2013
Trial Information
Current as of August 31, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called "not-celiac wheat sensitivity" (NCWS), which affects people who experience symptoms similar to irritable bowel syndrome (IBS) after eating wheat, but do not have celiac disease or a wheat allergy. The researchers want to understand what causes these symptoms and identify specific markers that could help diagnose NCWS. To do this, they will recruit adult patients who have seen their symptoms improve on a gluten-free diet and worsen when they eat gluten again.
Eligible participants for this study are adults between 18 and 65 years old who have IBS-like symptoms that improve when avoiding gluten and who have tested negative for celiac disease and wheat allergy. If you join the study, you will be randomly assigned to receive either wheat flour or a placebo (a harmless substance) for 15 days, and the researchers will monitor your symptoms before and after this period. They will also collect blood and tissue samples to look for possible markers of NCWS. This trial aims to enhance understanding of this condition and improve diagnosis for those affected.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients, both genders, with age between 18-65 years, with IBS-like symptoms, that improved on a gluten free diet and worsen on a gluten containing diet
- • Patients testing negative for celiac disease ( anti-tTG and EMA negative, and with biopsy Marsh 0-1) and wheat allergy (serum specific igE for wheat negative)
- Exclusion Criteria:
- • Subjects diagnosed with celiac disease (positive anti-tTG and/or EMA, and positive histology, with Marsh 2 or above);
- • Subjects diagnosed with wheat allergy (positive serum specific IgE for wheat)
- • Subjects with Type 1 Diabetes
- • Subjects with Inflammatory Bowel Diseases (Crohn's disease or ulcerative colitis)
- • Subjects with Helicobacter pylori infection and other gastrointestinal infection
- • Pregnancy
About University Of Palermo
The University of Palermo, a distinguished institution located in Italy, is dedicated to advancing medical research and education through innovative clinical trials. Renowned for its commitment to scientific excellence, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct research that addresses critical healthcare challenges. By fostering collaborations with leading researchers and healthcare professionals, the University of Palermo aims to translate scientific findings into effective therapies, ultimately contributing to improved patient outcomes and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sciacca, Agrigento, Italy
Palermo, , Italy
Patients applied
Trial Officials
Antonio Carroccio, PHD, MD
Principal Investigator
Internal Medicine, 'Giovanni Paolo II' Hospital of Sciacca (Agrigento) and University of Palermo, Palermo, Italy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials